|
Medartis Holding AG / Key word(s): Half Year Results Medartis 2023 half-year results presentation 25.07.2023 / 09:00 CET/CEST INVITATION │ AUDIO WEBCAST We are pleased to invite you to our H1 2023 results presentation on 15 August 2023. The following documents will be published on our corporate website and distributed to our newsletter subscribers at approx. 07:00 a.m. CET / Swiss time.
If you would like to subscribe to our mailing list, please use the following online form. The video webcast event will be held in English.
Audio webcast with Q&A:
Participant’s Link (also accessible through our website): https://event.swisscom.ch/v/medartis-hy2023 A recording of this online event will be immediately available at the same link for one month, as well as an MP4 file on our website shortly after the conference.
You can also connect via the following phone numbers:
Please dial in 5 minutes before the start of the conference and enter the keyword “Medartis” when prompted by the operator. To place a question verbally please press *1 and to withdraw press *2.
Kind regards, Medartis Corporate Communications Phone direct: +41 61 633 37 34 / +41 61 633 37 36 About Medartis Contact: Medartis US End of Media Release |
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment | Psychedelic Invest
Vancouver, Canada, Sept. 06, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on
September 12, 2024